PRESS RELEASE published on 06/10/2024 at 08:16, 4 months 8 days ago Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity Biophytis submits IND application to US FDA for phase 2 obesity study with BIO101 (20-hydroxyecdysone). Study to assess muscle strength & body composition. Research led by Professor Marc-André Cornier Biophytis BIO101 IND Application Obesity Study Professor Marc-André Cornier
PRESS RELEASE published on 06/10/2024 at 08:16, 4 months 8 days ago Biophytis annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité Biophytis annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité FDA Biophytis Étude De Phase 2 Obésité Demande D'IND
BRIEF published on 06/07/2024 at 08:28, 4 months 11 days ago Biophytis Announces Combined General Meeting on June 24, 2024 Shareholders Biophytis General Meeting Voting Agenda
BRIEF published on 06/07/2024 at 08:28, 4 months 11 days ago Assemblée générale mixte de Biophytis le 24 juin 2024 Actionnaires Biophytis Biotechnologie Assemblée Générale Vote
REGULATED PRESS RELEASE published on 06/07/2024 at 08:23, 4 months 11 days ago Combined General Meeting of June 24, 2024 Biophytis SA to hold Combined General Meeting (CGM) on June 24, 2024 in Paris. Shareholders encouraged to vote in advance via multiple methods. Details available on the company's website Shareholders Voting Combined General Meeting Biophytis SA CGM
REGULATED PRESS RELEASE published on 06/07/2024 at 08:23, 4 months 11 days ago Assemblée générale mixte du 24 juin 2024 Biophytis SA tiendra son Assemblée Générale Mixte le 24 juin 2024 à Paris. Les actionnaires sont encouragés à voter en amont. La société se concentre sur le développement de traitements pour les maladies liées à l'âge Assemblée Générale Mixte Biophytis SA Vote Actionnaires Traitements Maladies Liées À L'âge Développement Candidats Médicaments
BRIEF published on 06/07/2024 at 07:44, 4 months 11 days ago Assemblée générale mixte de Biophytis prévue le 24 juin 2024 Actionnaires Biophytis Paris Assemblée Générale Vote
BRIEF published on 06/07/2024 at 07:44, 4 months 11 days ago Biophytis Combined General Meeting scheduled for June 24, 2024 Shareholders Biophytis Paris General Assembly Vote
PRESS RELEASE published on 06/07/2024 at 07:39, 4 months 11 days ago Assemblée générale mixte du 24 juin 2024 Biophytis tiendra son Assemblée Générale Mixte le 24 juin 2024 à Paris. Les actionnaires sont invités à voter en amont par différents moyens. Infos sur le site web de la société Actionnaires Biophytis Assemblée Générale Société De Biotechnologie Vote
PRESS RELEASE published on 06/07/2024 at 07:39, 4 months 11 days ago Combined General Meeting of June 24, 2024 Biophytis to hold Combined General Meeting (CGM) on June 24, 2024 at Sorbonne Université. Shareholders urged to vote in advance. Company specializes in age-related disease therapeutics Shareholders Biophytis Therapeutics Combined General Meeting Age-related Diseases
Published on 10/18/2024 at 20:00, 22 minutes ago Western Alaska Minerals Announces Grant of Restricted Share Units
Published on 10/18/2024 at 15:00, 5 hours 22 minutes ago Namibia Critical Metals Receives Environmental Clearance Certificate for Mining Activities on its Lofdal Heavy Rare Earth Project
Published on 10/18/2024 at 14:31, 5 hours 51 minutes ago Vicinity Motor Corp. Receives Notice from RBC of Intent to File Receivership Order on Monday, October 21, 2024
Published on 10/18/2024 at 14:00, 6 hours 22 minutes ago Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions
Published on 10/18/2024 at 14:00, 6 hours 22 minutes ago NXT Energy Solutions to Present at the LD Micro Main Event XVII
Published on 10/18/2024 at 18:30, 1 hour 52 minutes ago For the track and the road: The new 911 GT3 and 911 GT3 with Touring package
Published on 10/18/2024 at 18:17, 2 hours 4 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 10/18/2024 at 18:00, 2 hours 21 minutes ago FLORENTAISE: Décalage de la publication des résultats annuels Chiffre d’affaires du 1er trimestre 2024-2025 : 9,3 M€ ; -6,4%
Published on 10/18/2024 at 18:00, 2 hours 22 minutes ago Notice of Termination of Invitation to Voluntary Tender to certain holders of Nebius Group N.V. Class A Ordinary Shares dated 16/10/2024
Published on 10/18/2024 at 18:55, 1 hour 26 minutes ago LDC : Accord en vue de l’acquisition de European Convenience Food (ECF) en Allemagne.
Published on 10/18/2024 at 18:55, 1 hour 26 minutes ago LDC : Entry into an agreement for the acquisition of European Convenience Food (ECF) in Germany.
Published on 10/18/2024 at 17:45, 2 hours 37 minutes ago TINC investeert in de veilige en vlotte doorstroming van de ringweg rond Brussel (B)
Published on 10/18/2024 at 17:45, 2 hours 37 minutes ago TINC invests in safe and smooth traffic on the Brussels ring road (B)
Published on 10/18/2024 at 17:45, 2 hours 37 minutes ago TINC invests in safe and smooth traffic on the Brussels ring road (B)